We have asked three clinician-researchers to outline some of the challenges of getting new therapies from the lab to the … En savoir plus
Participating in clinical trials
First Person – Else Manz At 58, I was proud of my healthy diet, active lifestyle and my near-empty medicine … En savoir plus
Benefits and risks of participating in a clinical trial
Benefits Clinical trials that are well-designed and well-executed offer excellent opportunities for eligible participants to: Play an active role in … En savoir plus
Ethical Issues in Clinical Trial Participation
Ann Heesters Director of Ethics and Spiritual Care Toronto Rehabilitation Institute Marleen Van Laethem Research Ethicist Toronto Rehabilitation Institute What … En savoir plus
Parkinson’s Medications… What you need to know! New information sheet
This information sheet will help you understand what types of medication are available to treat your Parkinson’s symptoms, the potential … En savoir plus
New directions in Parkinson’s treatments
Slowing down or modifying disease progression Current drugs for Parkinson’s treat the symptoms but do not stop the progression. One … En savoir plus
National Study of Neurological Conditions Gets Underway
It is with great excitement that we announce that the first-ever national study of neurological conditions in Canada is now … En savoir plus
New in Parkinson’s research
Chewing gum holds promise for people with Parkinson’s Family history of melanoma and Parkinson disease risk Toronto scientists awarded $150,000 … En savoir plus
W5 Program on Parkinson’s disease and Compulsive Behaviours
CTV’s W5 program is looking for people with Parkinson’s and care partners who are willing to share their personal stories … En savoir plus
Message from the editor
Welcome to the latest edition of E Parkinson Post! With Parkinson Society Canada poised to look back on almost 45 … En savoir plus
